Literature DB >> 9606007

Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.

R Löbenberg1, J Maas, J Kreuter.   

Abstract

The objective of the present study is to visualize differences in the body distribution between radiolabelled AZT bound to nanoparticles and a control solution. Polyhexylcyanoacrylate nanoparticles were manufactured by emulsion polymerization in the presence of AZT and an ionic emulsifier, bis(2-ethylhexyl) sulfosuccinate sodium. The AZT-control solution was equally prepared, but contained no monomer. The two preparations were administered either by i.v. injection or perorally by gavage. After determined time points the animals were sacrificed using carbon dioxide. The cadavers were shock-frozen in cellulose gel and cut into slices using a cryomicrotome. The tissue cross sections were fixed on an adhesive tape and then were freeze dried. The quantification of the radioactive AZT in the different organs and tissues was performed by radioluminography, and the images were generated on a computer. After i.v. injection of AZT-nanoparticles, a high amount of the AZT label was found in the organs belonging to the reticuloendothelial system. In these organs the radioactivity was inhomogeneously distributed showing that the uptake of the particle-associated radioactivity depended on the type of the cells located in the organs and was consistent with uptake by macrophages. The highest radioactivities were found in the GI-tract and in the liver. A difference in the elimination pathway between AZT-control solution and AZT bound to nanoparticles also was visible on the images. Similar results were obtained after oral administration. Of course, with the latter route a larger portion of AZT remained in the GI-tract especially after administration of nanoparticle-bound drug. These results confirmed those obtained by a classically performed quantitative whole body distribution study using liquid scintillation. This demonstrates that radioluminography is a useful method to study the organ distribution of drugs bound to nanoparticles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606007     DOI: 10.3109/10611869808995872

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  8 in total

1.  Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line.

Authors:  Niladri Chattopadhyay; Jason Zastre; Ho-Lun Wong; Xiao Yu Wu; Reina Bendayan
Journal:  Pharm Res       Date:  2008-05-31       Impact factor: 4.200

Review 2.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09

3.  Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.

Authors:  Kunchi Zhang; Shaowa Lv; Xiuyan Li; Yufei Feng; Xin Li; Lu Liu; Shuang Li; Yongji Li
Journal:  Int J Nanomedicine       Date:  2013-08-22

4.  Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices.

Authors:  Sonal Mazumder; Ashish Kumar Dewangan; Naresh Pavurala
Journal:  Asian J Pharm Sci       Date:  2017-07-08       Impact factor: 6.598

5.  Gold Nanorods for Doxorubicin Delivery: Numerical Analysis of Electric Field Enhancement, Optical Properties and Drug Loading/Releasing Efficiency.

Authors:  Muhammad Qamar; Ghulam Abbas; Muhammad Afzaal; Muhammad Y Naz; Abdul Ghuffar; Muhammad Irfan; Stanislaw Legutko; Jerzy Jozwik; Magdalena Zawada-Michalowska; Abdulnour Ali Jazem Ghanim; Saifur Rahman; Usama M Niazi; Mohammed Jalalah; Fahad Salem Alkahtani; Mohammad K A Khan; Ewelina Kosicka
Journal:  Materials (Basel)       Date:  2022-02-26       Impact factor: 3.623

Review 6.  Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections.

Authors:  Upal Roy; Paul Barber; Yuk-Ching Tse-Dinh; Elena V Batrakova; Debasis Mondal; Madhavan Nair
Journal:  Front Microbiol       Date:  2015-09-17       Impact factor: 5.640

Review 7.  Therapeutic Nanoparticles and Their Targeted Delivery Applications.

Authors:  Abuzer Alp Yetisgin; Sibel Cetinel; Merve Zuvin; Ali Kosar; Ozlem Kutlu
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

Review 8.  Polymeric particulates to improve oral bioavailability of peptide drugs.

Authors:  Florence Delie; María José Blanco-Príeto
Journal:  Molecules       Date:  2005-01-31       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.